Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · IEX Real-Time Price · USD

5.42

+0.06 (1.12%)

At close: Apr 19, 2024, 4:00 PM

5.30

-0.12 (-2.21%)

After-hours: Apr 19, 2024, 7:59 PM EDT

Amneal Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	2,394	2,212	2,094	1,993	1,626	1,663	1,034	1,018	866.28	785.62
Revenue Growth (YoY)	8.20%	5.67%	5.08%	22.51%	-2.20%	60.88%	1.52%	17.54%	10.27%	-
Cost of Revenue	1,573	1,428	1,325	1,364	1,273	946.59	507.48	420.77	364.6	337.2
Gross Profit	820.57	784.71	768.97	628.39	353	716.4	526.18	597.46	501.68	448.42
Selling, General & Admin	429.68	399.7	365.5	326.73	289.6	227.85	109.05	118.76	97.18	84.62
Research & Development	163.95	195.69	201.85	179.93	188.05	194.19	171.42	179.02	136.87	106.74
Other Operating Expenses	37.06	283.52	48.71	30.58	124.03	314.04	0.61	14.8	31.48	38.5
Operating Expenses	630.69	878.91	616.06	537.24	601.68	736.08	281.08	312.57	265.53	229.85
Operating Income	189.88	-94.2	152.92	91.16	-248.68	-19.67	245.1	284.88	236.16	218.58
Interest Expense / Income	210.63	158.38	136.33	146	168.21	143.57	71.06	55.28	45.84	30.66
Other Expense / Income	54.79	-129.25	-5.23	-41.54	-438.3	-140.91	172.04	224.2	15.92	9.47
Pretax Income	-75.54	-123.32	21.82	-13.3	21.41	-22.34	2	5.4	174.4	178.44
Income Tax	8.45	6.66	11.2	-104.36	383.33	-1.42	2	5.4	4.95	1.51
Net Income	-83.99	-129.99	10.62	91.06	-361.92	-20.92	0	0	169.45	176.93
Net Income Growth	-	-	-88.33%	-	-	-	-	-	-4.23%	-
Shares Outstanding (Basic)	176	151	149	147	132	127	298	298	-	-
Shares Outstanding (Diluted)	176	151	152	149	132	127	-	-	-	-
Shares Change	16.69%	-0.58%	1.95%	12.72%	3.81%	-57.36%	-	-	-	-
EPS (Basic)	-0.48	-0.86	0.07	0.62	-2.74	-0.16	-	-	-	-
EPS (Diluted)	-0.48	-0.86	0.07	0.61	-2.74	-0.16	-	-	-	-
EPS Growth	-	-	-88.52%	-	-	-	-	-	-	-
Free Cash Flow	298.78	16.31	190.88	317.17	-45.48	192.49	139.42	-7.7	-12.5	32.87
Free Cash Flow Per Share	1.70	0.11	1.28	2.15	-0.34	1.51	0.47	-0.03	-	-
Gross Margin	34.28%	35.47%	36.73%	31.54%	21.70%	43.08%	50.90%	58.68%	57.91%	57.08%
Operating Margin	7.93%	-4.26%	7.30%	4.57%	-15.29%	-1.18%	23.71%	27.98%	27.26%	27.82%
Profit Margin	-3.51%	-5.88%	0.51%	4.57%	-22.25%	-1.26%	-	-	19.56%	22.52%
Free Cash Flow Margin	12.48%	0.74%	9.12%	15.92%	-2.80%	11.57%	13.49%	-0.76%	-1.44%	4.18%
Effective Tax Rate	-	-	51.31%	-	1790.10%	-	100.00%	100.00%	2.84%	0.85%
EBITDA	364.49	275.23	391.55	368.09	396.85	258.64	119	93.69	245.68	229.45
EBITDA Margin	15.23%	12.44%	18.70%	18.47%	24.40%	15.55%	11.51%	9.20%	28.36%	29.21%
Depreciation & Amortization	229.4	240.18	233.41	235.39	207.24	137.4	45.94	33.02	25.45	20.34
EBIT	135.09	35.05	158.15	132.7	189.62	121.23	73.06	60.68	220.24	209.11
EBIT Margin	5.64%	1.58%	7.55%	6.66%	11.66%	7.29%	7.07%	5.96%	25.42%	26.62%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).